News
Press Release
Careers
Life at Hikal
Career Opportunities
Contact Us
Visit us
Get in touch
Toggle navigation
About
Who We Are
Mission & Vision
The Hikal Way
Sustainability
Team Hikal
Facilities
Pharmaceuticals
Offerings
Contract Development &
Manufacturing
APIs and Intermediates
Animal Health
Project Management
Facilities
Crop Protection
Overview
Offerings
Capabilities
Project Management
Facilities
Specialty Chemicals
Offerings
Facilities
Research & Technology
Overview
Infrastructure
Scientific Advisory Board
Facility
Investor Relations
Presentations
Investor Information
Company Fact Sheet
Company Announcements
Shareholding Pattern
EOGM
TDS on Dividend
IEPF/Dividend/ Share
Investor Services Forms
Financials
Annual Reports
Financial Results
Press Release
Financial Highlights
Investor Call Transcripts
Related Party Transactions
Investor's Contact
Corporate Governance
AGM
Postal Ballot
Toggle navigation
About
Who We Are
Mission & Vision
The Hikal Way
Sustainability
Team Hikal
Facilities
Pharmaceuticals
Offerings
Contract Development &
Manufacturing
APIs and Intermediates
Animal Health
Project Management
Facilities
Crop Protection
Overview
Offerings
Capabilities
Project Management
Facilities
Specialty Chemicals
Offerings
Facilities
Research & Technology
Overview
Infrastructure
Scientific Advisory Board
Facility
Investor Relations
Presentations
Investor Information
Company Fact Sheet
Company Announcements
Shareholding Pattern
EOGM
TDS on Dividend
IEPF/Dividend/ Share
Investor Services Forms
Financials
Annual Reports
Financial Results
Press Release
Financial Highlights
Investor Call Transcripts
Related Party Transactions
Investor's Contact
Corporate Governance
AGM
Postal Ballot
News
Press Release
Careers
Life at Hikal
Career Opportunities
Contact Us
Visit us
Get in touch
Company Announcements
Investor Relations > Investor Information >
Home >
Company Fact Sheet
Company Announcements
Shareholding Pattern
Unclaimed Dividends
Transfer Of Shares To IEPF
EOGM
TDS on Dividend
IEPF/Dividend/ Share
Investor Services Forms
PDF
Intimation under Regulation 30-Appointment of Independent Directors
PDF
Disclosure Under Regulation 30A of SEBI (LODR) Regulations, 2015
PDF
Intimation under Regulation 30 Panoli Direction Disclosure - Update
PDF
Hikal Q1 FY24 Earnings Call Invite
PDF
Intimation under Regulation 30 Panoli Direction Disclosure
PDF
Trading Window Closure Notice June 2023
PDF
Draft of Model Tripartite Agreement between the issuer, existing Share Transfer Agent and new Share Transfer Agent
PDF
Hikal Q4FY23 Earnings Call Transcript
PDF
Special Trading Window Closure May 31. 2023
PDF
Conference Intimation under Regulation 30
PDF
Hikal Q4FY23 Earnings Call Invite
PDF
Hikal response to Report by InGovern
PDF
Hikal Press Release US FDA Audit
PDF
Trading Window Closure Notice March 2023
PDF
Announcement under Regulation 30 of SEBI (LODR), 2015
PDF
Hikal Q3FY23 Earnings Call Invite
PDF
Trading Window Closure Notice December 2022
PDF
Announcement under Regulation 30 - Update
PDF
Announcement under Regulation 30
PDF
Announcement under Regulation 30 - Acquisition
PDF
Announcement under Reg 30 -writ petition against NGT order
PDF
Trading Window Closure Notice March 2022
PDF
Annoncement under Regulation 30 of SEBI(LODR) Regulations, 2015
PDF
Announcement under Regulation 30 of SEBI (LODR) Regulation, 2015
PDF
Hikal Q1FY22 Earnings Call Invite
PDF
Announcement under Regulation 30 of SEBI (LODR) Regulation, 2015 - Update
PDF
Announcement under Regulation 30 of SEBI (LODR) Regulations, 2015
PDF
Trading Window Closure Notice September 2021
PDF
Intimation of Schedule of Institutional Investor meeting
PDF
Hikal Q3FY22 Earnings Call Invite
PDF
SE Notification on Halt in Mahad Operations
PDF
FY 2020 Q4 Concall Invite
PDF
Hikal Outcome of BM 14-02-2022
PDF
Trading Window Closure Notice September 2022
PDF
Hikal Q2FY23 Earnings Call Invite
PDF
Hikal COVID 19 Stock Exchange Notification 06-04-2020
PDF
Trading Window Closure Notice December 2021
PDF
Hikal COVID 19 Stock Exchange Notification 26-03-2020
PDF
Hikal Q1FY23 Earnings Call Invite
PDF
Announcement under Regulation 30 of SEBI (LODR) Regulations, 2015.Update
PDF
Disclosue of change in Directorate
PDF
Trading Window June 2021
PDF
Hikal Credit Rating Intimation BSE NSE 06-11-2019
PDF
SE Notification On Resuming Oxygen Supply 10-06-2021
PDF
Credit Rating Intimation November-2016
PDF
Hikal Q4FY22 Earnings Call Invite
PDF
Hikal Intimation of Investors Meet May 2021
PDF
Credit Rating Intimation 30-07-2018
PDF
FY 2017-18 Q2 BM Notice
PDF
Stock Exchange Intimation Non Availability of Industrial Oxygen
PDF
Update on Plant Operations of The Company 28-10-2019
PDF
Intimation of Investor Meet September-2016
PDF
SAST Disclosure
PDF
Hikal Q2FY22 Earnings Call Invite
PDF
Credit Rating Intimation August 2017
PDF
Intimation of Cutoff date for evoting
PDF
FY 2017-18 Q1 BM Notice
PDF
Reappointment of Mrs. Shivani Bhasin Sachdeva as Independent Director
PDF
Intimation of Investor Meet June-2017
PDF
Hikal FY21 Q4 Investor & Analyst Meet
PDF
Intimation of Investor Meet June-2016
PDF
Submission of Investor Presentation June 2017
PDF
Trading Window Closure Notice June 2022
PDF
Intimation of Book Closure Notice
PDF
Disclosure regarding KMPs of Hikal
PDF
FY 2016-17 Q4BM Notice
PDF
Intimation of revision in Credit Rating Dec-15-2021
PDF
Ltr BSE,NSE Earnings Call Invite
PDF
Intimation of Investor Meet February 2017
PDF
Announcement under Regulation 30 of SEBI (LODR) Regulation, 2015. Update
PDF
Submission of Investor Presentation February 2016
PDF
Declaration of Int Dividend
PDF
FY 2016-17 Q3 BM Notice
PDF
SE Notification on Resumption of Mahad Operations
PDF
Hikal_Q2 FY21 Concall Invite
PDF
Trading Window Qtrend March 2021
PDF
Declaration Of Rd For Stock Split
PDF
Sale of R&D Property Bangalore
PDF
Hikal SE Intimation Reopening of Taloja Plant